AI brief of an SEC Form 8-K · Victory Capital Holdings (VCTR)

Victory Capital closes Amundi US deal, issues 17.6 million shares to Amundi

Mixed Impact 4 of 5 m&a Written later

Victory Capital completed its acquisition of Amundi US on April 1, 2025, issuing Amundi 17.6 million shares, or 21.2% of fully diluted equity, with additional shares expected over six months to bring Amundi's stake to 26.1%. The company raised its net expense synergy target to $110 million from $100 million and expects to achieve it sooner than originally planned. Existing shareholders will own a smaller share of the company, and two Amundi designees joined the board.

Key points

  • Closed April 1, 2025; issued 3,293,471 common shares (4.9%) and 14,305,982 non-voting Series A convertible preferred shares, together 21.2% of fully diluted shares
  • Net expense synergy target raised from $100 million to $110 million; about $50 million achieved at closing
  • Pioneer Investments generated 2024 revenue of $544 million and had $119 billion in assets under management as of February 28, 2025
  • Robert Hurst retired from the board effective April 1; Céline Boyer-Chammard and Dominique Carrel-Billiard joined as Amundi designees

The filing

CompanyVictory Capital Holdings (VCTR)
Form8-K, current report
Filed with the SECApr 3, 2025, 4:19 PM ET
Accession number0001104659-25-031690

Items reported: 1.01 Material Definitive Agreement2.01 Acquisition or Disposition Completed3.02 Unregistered Equity Sale5.02 Director / Officer Change5.03 Bylaw / Charter Amendment7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 03, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.